Insmed (INSM) Assets (2011 - 2026)
Insmed's (INSM) quarterly Assets came in at $2.1 billion in Q1 2026, up 15.15% year-on-year from $1.8 billion in Q1 2025, and down 8.33% quarter-over-quarter from $2.3 billion in Q4 2025.
Insmed (INSM) Assets (2011 - 2026) Analysis & Trends
Insmed's Assets history runs 16 years deep, the most recent figure standing at $2.1 billion for Q1 2026.
- On a quarterly basis, Assets rose 15.15% year-over-year to $2.1 billion in Q1 2026; TTM through Mar 2026 was $2.1 billion, a 15.15% increase from a year earlier, with the FY2025 full-year figure at $2.3 billion, up 11.82% from the prior year.
- Assets retreated to $2.1 billion in Q1 2026 per INSM's latest filing, from $2.3 billion in the prior quarter.
- Across five years, Assets topped out at $2.5 billion in Q2 2025 and bottomed at $994.8 million in Q3 2022.
- The 5-year median for Assets is $1.7 billion (2022), against an average of $1.7 billion.
- Biggest YoY gain for Assets was 66.57% in 2022; the steepest drop was 24.16% in 2022.
- Year by year, Assets stood at $1.7 billion in 2022, then retreated by 19.72% to $1.3 billion in 2023, then surged by 52.29% to $2.0 billion in 2024, then climbed by 11.82% to $2.3 billion in 2025, then declined by 8.33% to $2.1 billion in 2026.
- Per Business Quant, the three latest INSM Assets figures stand at $2.1 billion (Q1 2026), $2.3 billion (Q4 2025), and $2.4 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 311.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 78.88 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.55 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 39.68 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.48 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.87 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 811.27 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 10.03 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.25 Bn |
| 10 | Insmed | 23.26 Bn | 22.03 Bn | 258.54 Mn | 2.08 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.08 Bn |
| Dec 31, 2025 | 2.26 Bn |
| Sep 30, 2025 | 2.36 Bn |
| Jun 30, 2025 | 2.48 Bn |
| Mar 31, 2025 | 1.80 Bn |
| Dec 31, 2024 | 2.03 Bn |
| Sep 30, 2024 | 2.05 Bn |
| Jun 30, 2024 | 1.81 Bn |
| Mar 31, 2024 | 1.16 Bn |
| Dec 31, 2023 | 1.33 Bn |
| Sep 30, 2023 | 1.32 Bn |
| Jun 30, 2023 | 1.44 Bn |
| Mar 31, 2023 | 1.52 Bn |
| Dec 31, 2022 | 1.66 Bn |
| Sep 30, 2022 | 994.82 Mn |
| Jun 30, 2022 | 1.05 Bn |
| Mar 31, 2022 | 1.15 Bn |
| Dec 31, 2021 | 1.24 Bn |
| Sep 30, 2021 | 1.31 Bn |
| Jun 30, 2021 | 1.23 Bn |